Outcome variation among "radioresistant" brain metastases treated with stereotactic radiosurgery.

@article{Chang2005OutcomeVA,
  title={Outcome variation among "radioresistant" brain metastases treated with stereotactic radiosurgery.},
  author={Eric L. Chang and Uğur Selek and Samuel J. Hassenbusch and Moshe H. Maor and Pamela K. Allen and A. O. Mahajan and Raymond A Sawaya and Shiao Y. Woo},
  journal={Neurosurgery},
  year={2005},
  volume={56 5},
  pages={936-45; discussion 936-45}
}
OBJECTIVE To determine the influence of histopathological diagnosis on the outcome of "radioresistant" brain metastases treated with stereotactic radiosurgery (SRS). METHODS Patients (n = 189) with "radioresistant" brain metastases (n = 264) were consecutively treated with SRS between August 1991 and July 2002. The primary site of brain metastases was melanoma (n = 103), renal cell carcinoma (n = 77), and sarcoma (n = 9). The median age of the patients was 52 years, and the median Karnofsky… CONTINUE READING